In this video interview, Umesh Chaudhari, executive medical director and global program head of the C5 programs at Regeneron, ...

Generative artificial intelligence (AI) has absolutely exploded onto the scene. It's become a top strategic priority in the ...

Kalaris Therapeutics initiates a phase 1b/2 study for TH103, targeting neovascular age-related macular degeneration and ...

For many people living with neurodegenerative diseases or recovering from stroke, daily routines can become exhausting challenges. Simple actions like brushing teeth, raising a fork, or combing hair ...

Hybrid PET/MRI combines detailed anatomical imaging from multiparametric MRI with metabolic data from PET scanning, offering ...

A test of GutGPT, a specialized AI system for emergency bleeding cases, reveals how medical teams really interact with AI and ...

Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral small molecules targeting RNA and RNA regulation for oncology and neurological disorders, ...

A successful design and development process must balance exploration with structure, enabling teams to build high-quality products efficiently while adapting to change along the way. Yet, while the ...

The Seattle-based biotech company aims to make new drug discovery faster and cheaper by using AI to simulate the results from ...

A large-scale study analyzing over a million births in Sweden found no evidence that prescribed opioid pain medications during pregnancy cause autism or ADHD in children.

A Hollywood Smile is one of the most transformative and sought after cosmetic procedures in the world, promising a flawless, ...